Association between left ventricular diastolic dysfunction and septic acute kidney injury in severe sepsis and septic shock: A multicenter retrospective study

Perfusion ◽  
2021 ◽  
pp. 026765912198896
Author(s):  
Guangwei Yu ◽  
Kun Cheng ◽  
Qing Liu ◽  
Xiaohong Lin ◽  
Fenghui Lin ◽  
...  

Introduction: Left ventricular diastolic dysfunction (LVDD) adversely impacts renal function, and E/e′ is a significant predictor of adverse kidney events under different clinical conditions. However, no studies have evaluated the association between LVDD and septic acute kidney injury (AKI) among patients with severe sepsis and septic shock. Methods: This multicenter retrospective study evaluated adult patients with severe sepsis or septic shock between January 1, 2013, and December 31, 2019, who underwent echocardiography within 24 hours after admission to an intensive care unit. Results: A total of 495 adult patients were enrolled in the study. LVDD grades II and III were associated with severe (stage 3) AKI ( p < 0.001, p for trend < 0.001). E/e′ and e′ were risk factors for septic AKI (OR, 1.155; 95% CI, 1.088–1.226, p < 0.001; and OR, 7.218; 95% CI, 2.942–17.712, p < 0.001, respectively) in the multivariate logistic regression analysis. The area under the receiver operating characteristic curve of E/e′ and e′ was 0.728 (95% CI, 0.680–0.777, p < 0.001) and 0.715 (95% CI, 0.665–0.764, p < 0.001), respectively. Conclusions: LVDD was associated with septic AKI, and E/e′ and e′ are useful predictors of septic AKI among patients with severe sepsis or septic shock. Trial registration The study was registered at the Chinese Clinical Trial Registry (Protocol No. ChiCTR2000033083).

2015 ◽  
Vol 30 (1) ◽  
pp. 97-101 ◽  
Author(s):  
Fernando Saes Vilaça de Oliveira ◽  
Flavio Geraldo Resende Freitas ◽  
Elaine Maria Ferreira ◽  
Isac de Castro ◽  
Antonio Toneti Bafi ◽  
...  

2012 ◽  
Vol 344 (5) ◽  
pp. 350-356 ◽  
Author(s):  
Jin Won Huh ◽  
Chae-Man Lim ◽  
Younsuck Koh ◽  
Sang-Bum Hong ◽  
Won Young Kim

PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0127411 ◽  
Author(s):  
Marion Venot ◽  
Lise Weis ◽  
Christophe Clec’h ◽  
Michael Darmon ◽  
Bernard Allaouchiche ◽  
...  

2018 ◽  
Vol 3 (6) ◽  
pp. 1424-1433 ◽  
Author(s):  
Alexa Hollinger ◽  
Xavier Wittebole ◽  
Bruno François ◽  
Peter Pickkers ◽  
Massimo Antonelli ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (6) ◽  
pp. e35838 ◽  
Author(s):  
Didier Payen ◽  
Anne-Claire Lukaszewicz ◽  
Matthieu Legrand ◽  
Etienne Gayat ◽  
Valérie Faivre ◽  
...  

2020 ◽  
Author(s):  
Guangwei Yu ◽  
Kun Cheng ◽  
Qing Liu ◽  
Zhenhao Zhu ◽  
Fenghui Lin ◽  
...  

Abstract Background: Baseline left ventricular (LV) dysfunction is associated with subsequent risks of acute kidney injury (AKI) and mortality in patients with sepsis. This study investigated the therapeutic effects of continuous renal replacement therapy (CRRT) in hemodynamically unstable patients with severe sepsis and septic shock combined with LV dysfunction.Methods: In this multicenter retrospective study, severe sepsis and septic shock patients with LV dysfunction were classified into one of two groups according to the timing of CRRT: the early group (before AKI was detected) or the control group (patients with AKI). All-cause intensive care unit (ICU) mortality and ICU stay were compared between the groups. Patients were weighted by stabilized inverse probability of treatment weights (sIPTW) to overcome differences in baseline characteristics.Results: After sIPTW analysis, the ICU mortality was significantly lower in the early group than the control group (25.9% vs 59.0%, p < 0.001). Weighted multivariable analysis showed that early CRRT initiation was a protective factor for the risk of ICU mortality. Early CRRT initiation significantly improved the ICU mortality compared to the control group (OR, 0.322; 95% CI, 0.125-0.834; p = 0.020).Conclusions: Early CRRT in the absence of AKI is suggested for hemodynamically unstable patients with severe sepsis and septic shock combined with LV dysfunction since it benefits survival outcomes.Trial registration: The study was preregistered in the Chinese Clinical Trial Registry (number, ChiCTR2000033083).


Sign in / Sign up

Export Citation Format

Share Document